Cargando…

Erratum for Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis

Detalles Bibliográficos
Autores principales:	Nemoto, Tetsuya, Ito, Satoshi, Kobayashi, Daisuke, Takai, Chinatsu, Sakai, Syunsuke, Kurosawa, Youichi, Hasegawa, Eriko, Okabayashi, Ryo, Abe, Asami, Otani, Hiroshi, Lee, Hyunho, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi, Toyoshima, Yoichi, Inagaki, Katunori, Ishikawa, Hajime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313909/ https://www.ncbi.nlm.nih.gov/pubmed/34193776 http://dx.doi.org/10.2169/internalmedicine.E004-21

Ejemplares similares

Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis
por: Nemoto, Tetsuya, et al.
Publicado: (2020)

Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis
por: Kurosawa, Yoichi, et al.
Publicado: (2022)

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2018)

The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023)

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
por: Hasegawa, Eriko, et al.
Publicado: (2018)

Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
por: Takai, Chinatsu, et al.
Publicado: (2020)

Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
por: Takai, Chinatsu, et al.
Publicado: (2021)

The Combination of Modified Mitchell’s Osteotomy and Shortening Oblique Osteotomy for Patients with Rheumatoid Arthritis: An Analysis of Changes in Plantar Pressure Distribution
por: Lee, Hyunho, et al.
Publicado: (2021)

Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report
por: Sato, Hiroe, et al.
Publicado: (2014)

An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2017)

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis
por: Kobayashi, Tetsuo, et al.
Publicado: (2016)

Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
por: Kobayashi, Tetsuo, et al.
Publicado: (2015)

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
por: Sato, Hiroe, et al.
Publicado: (2020)

False‐positive semiquantitative immunochromatography assays for procalcitonin in three patients with rheumatoid arthritis—A case series
por: Sato, Hiroe, et al.
Publicado: (2020)

Giant Cell Arteritis That Presented with Buccal Skin Ulceration along the Facial Artery
por: Hasegawa, Eriko, et al.
Publicado: (2022)

Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis
por: Azuma, Naoto, et al.
Publicado: (2017)

Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Relationship between disease activity level and physical activity in rheumatoid arthritis using a triaxial accelerometer and self-reported questionnaire
por: Toyoshima, Yoichi, et al.
Publicado: (2021)

Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Therapeutic failure and eventual solution for skin necrosis and exposed tendon of the dorsum of the foot: A case report
por: Toyoshima, Yoichi, et al.
Publicado: (2018)

Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study
por: Kaneko, Chihiro, et al.
Publicado: (2018)

Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis—possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report
por: Habuka, Masato, et al.
Publicado: (2018)

Safety and clinical efficacy of golimumab in the treatment of arthritides
por: Simsek, Ismail, et al.
Publicado: (2010)

SAT-LB87 Golimumab Induced Thyroiditis
por: Mai, Mo M, et al.
Publicado: (2020)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study
por: Okabayashi, Yusuke, et al.
Publicado: (2018)

Spontaneous Peripelvic Urinary Extravasation and Internal Iliac Aneurysm
por: Iwafuchi, Yoichi, et al.
Publicado: (2020)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

Effectiveness of Golimumab in Clinical Management of Patients with Rheumatoid Arthritis
por: Shono, Eisuke
Publicado: (2013)

Golimumab: A Novel Anti-Tumor Necrosis Factor
por: Rossini, Maurizio, et al.
Publicado: (2013)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Ocular toxicity of intravitreal golimumab in a rabbit model
por: DURMAZ ENGİN, Ceren, et al.
Publicado: (2020)

Acute Kidney Injury Associated with Minimal Change Nephrotic Syndrome in an Elderly Patient Successfully Treated with both Fluid Management and Specific Therapy Based on Kidney Biopsy Findings
por: Oyama, Yuko, et al.
Publicado: (2020)

Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis
por: William, Mridula, et al.
Publicado: (2012)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Predictive Factors Related to the Efficacy of Golimumab in Patients with Rheumatoid Arthritis
por: Kanbe, Katsuaki, et al.
Publicado: (2015)

An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
por: Paccou, Julien, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hh8f0ru03kmod5i0c8tk1r40j7